Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 221.00 | 259.50 | 0.8516 | 0.4744 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 257.00 | 259.50 | 0.9904 | 0.9636 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 805.00 | 595.50 | 1.3518 | 2.0900 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 640.00 | 595.50 | 1.0747 | 1.2192 | |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 4 | 625.00 | 368.38 | 694.00 | 595.50 | 1.1654 | 1.4944 |
| SK-BR-3 | Omipalisib | 1 | uM | 4 | 625.00 | 368.38 | 254.00 | 595.50 | 0.4265 | -0.4152 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 4 | 625.00 | 368.38 | 769.00 | 595.50 | 1.2914 | 1.8926 |
| SK-BR-3 | Taxol | 0.031623 | uM | 4 | 625.00 | 368.38 | 316.00 | 595.50 | 0.5307 | -0.1985 |
| SK-BR-3 | Palbociclib | 10 | uM | 4 | 625.00 | 368.38 | 373.00 | 595.50 | 0.6264 | 0.0182 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 4 | 625.00 | 368.38 | 497.00 | 595.50 | 0.8346 | 0.5407 |
| SK-BR-3 | Taxol | 0.01 | uM | 4 | 625.00 | 368.38 | 286.00 | 595.50 | 0.4803 | -0.3060 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 4 | 625.00 | 368.38 | 509.00 | 595.50 | 0.8547 | 0.5946 |
| SK-BR-3 | Methotrexate | 0.01 | uM | 4 | 625.00 | 368.38 | 614.00 | 595.50 | 1.0311 | 1.0903 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 4 | 625.00 | 368.38 | 1039.00 | 595.50 | 1.7448 | 3.4657 |
| SK-BR-3 | Taxol | 0.00033113 | uM | 4 | 625.00 | 368.38 | 798.00 | 595.50 | 1.3401 | 2.0513 |
| SK-BR-3 | Palbociclib | 0.1 | uM | 4 | 625.00 | 368.38 | 596.00 | 595.50 | 1.0008 | 1.0024 |
| SK-BR-3 | Omipalisib | 10 | uM | 4 | 625.00 | 368.38 | 173.00 | 595.50 | 0.2905 | -0.6640 |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 458.00 | 595.50 | 0.7691 | 0.3693 | |
| SK-BR-3 | Palbociclib | 1 | uM | 4 | 625.00 | 368.38 | 372.00 | 595.50 | 0.6247 | 0.0142 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 4 | 625.00 | 368.38 | 519.00 | 595.50 | 0.8715 | 0.6400 |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 4 | 625.00 | 368.38 | 472.00 | 595.50 | 0.7926 | 0.4301 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 4 | 625.00 | 368.38 | 415.00 | 595.50 | 0.6969 | 0.1877 |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 4 | 625.00 | 368.38 | 386.00 | 595.50 | 0.6482 | 0.0698 |
| SK-BR-3 | Taxol | 0.1 | uM | 4 | 625.00 | 368.38 | 238.00 | 595.50 | 0.3997 | -0.4676 |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 615.00 | 595.50 | 1.0327 | 1.0952 |